tirzepatide lakeway for Weight Loss Medically Managed Weight Loss in
Description
(average results) Wegovy (semaglutide) GLP-1 only In the STEP-1 study (68 weeks), average weight change was about: 14.9% with Wegovy 2.4% with placebo (dummy injection) What that looks like: If you start at 100 kg , 14.9% is about 15 kg lost on average
They are also forbidden from "misleading" advertising and using any Novo Nordisk trademarks or logos in their products
Active ingredient: Tirzepatide Dosages: 2.5 15 mg / week Tirzepatide is a dual receptor agonist it acts on the GLP-1 and GIP gut-hormone receptors at the same time
Tirzepatide is generally taken once weekly
Programmatic healthcare advertising is also evolving
